cache/cc14066c82e1a4b27a0ead9436437633619020567c845abf9e8a41e30619917a

NASDAQ:GUTS

Fractyl Laboratories

  • Stock

USD

Last Close

1.09

06/11 21:53

Market Cap

214.10M

Beta: -

Volume Today

157.12K

Avg: 852.05K

PE Ratio

−1.36

PFCF: −2.00

    Description

    Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also deve...Show More

    Earnings

    Earnings per Share (Estimate*)

    -8-6-4-22020-09-282021-09-292022-12-292023-06-292024-08-142025-05-12

    Revenue (Estimate*)

    20K40K60K80K2020-09-282021-09-292022-12-292023-06-292024-08-142025-05-12

    *Estimate based on analyst consensus